Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Holmes

Showing results (801-810 of 880) with videos related to

Pageof 88
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2012
Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiationMichael L Beshiri, Katherine B Holmes, William F Richter, et al.
Plos Medicine|January 13, 2018
Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based surveyCharles B Holmes, Izukanji Sikazwe, Kombatende Sikombe, et al.
The EMBO Journal|April 23, 2004
Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectorsStephen K Dove, Robert C Piper, Robert K McEwen, et al.
Epilepsia|November 14, 2024
Epilepsy-pregnancy registries: An updatePiero Perucca, Dina Battino, Rebecca Bromley, et al.
The EMBO Journal|December 20, 2003
Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteinsNael Nadif Kasri, Anthony M Holmes, Geert Bultynck, et al.
Journal of the International AIDS Society|February 25, 2023
Trajectories of re-engagement: factors and mechanisms enabling patient return to HIV care in ZambiaLaura K Beres, Chanda Mwamba, Carolyn Bolton-Moore, et al.
Nature Communications|November 3, 2025
Determination of key functional structures of an amorphous VHL-based SMARCA2 PROTACDaria Torodii, Jacob B Holmes, Manuel Cordova, et al.
The Lancet. Global Health|December 5, 2025
Future directions: ending HIV in Africa-a call to action for sustainable and nationally led preventionMumbi Chola, Kenneth Ngure, Lloyd Mulenga, et al.
Plos Medicine|June 6, 2018
Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in ZambiaAaloke Mody, Izukanji Sikazwe, Nancy L Czaicki, et al.
The Journal of Biological Chemistry|January 25, 2020
A synthetic heparinoid blocks Tau aggregate cell uptake and amplificationBarbara E Stopschinski, Talitha L Thomas, Sourena Nadji, et al.
Pageof 88

Showing results (801-810 of 880) with videos related to

Sort By:
Pageof 88
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2012
Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiationMichael L Beshiri, Katherine B Holmes, William F Richter, et al.
Plos Medicine|January 13, 2018
Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based surveyCharles B Holmes, Izukanji Sikazwe, Kombatende Sikombe, et al.
The EMBO Journal|April 23, 2004
Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectorsStephen K Dove, Robert C Piper, Robert K McEwen, et al.
Epilepsia|November 14, 2024
Epilepsy-pregnancy registries: An updatePiero Perucca, Dina Battino, Rebecca Bromley, et al.
The EMBO Journal|December 20, 2003
Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteinsNael Nadif Kasri, Anthony M Holmes, Geert Bultynck, et al.
Journal of the International AIDS Society|February 25, 2023
Trajectories of re-engagement: factors and mechanisms enabling patient return to HIV care in ZambiaLaura K Beres, Chanda Mwamba, Carolyn Bolton-Moore, et al.
Nature Communications|November 3, 2025
Determination of key functional structures of an amorphous VHL-based SMARCA2 PROTACDaria Torodii, Jacob B Holmes, Manuel Cordova, et al.
The Lancet. Global Health|December 5, 2025
Future directions: ending HIV in Africa-a call to action for sustainable and nationally led preventionMumbi Chola, Kenneth Ngure, Lloyd Mulenga, et al.
Plos Medicine|June 6, 2018
Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in ZambiaAaloke Mody, Izukanji Sikazwe, Nancy L Czaicki, et al.
The Journal of Biological Chemistry|January 25, 2020
A synthetic heparinoid blocks Tau aggregate cell uptake and amplificationBarbara E Stopschinski, Talitha L Thomas, Sourena Nadji, et al.
Pageof 88